IMM.L
ImmuPharma plc [IMM.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IMM.L Stock Summary
Top IMM.L Correlated Resources
IMM.L
Top 10 Correlated ETFs
IMM.L
Top 10 Correlated Stocks
IMM.L
IMM.L Financial details
Company Rating
-
Market Cap
0
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
100%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
52
Rel Volume
-
Avg Volume
-
Volume
1.41M
Perf Week
-5.31%
Perf Month
29.7%
Perf Quarter
22.99%
Perf Half Y
25.15%
-
-
-
-
Beta
-
-
-
Volatility
0.09%, 0.25%
Prev Close
-0.93%
Price
2.14
Change
-14.4%
IMM.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-12-31
| Metric | History | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.05 | -0.05 | -0.05 | -0.04 | -0.03 | |
| Operating cash flow per share | -0.06 | -0.03 | -0.03 | -0.03 | -0.02 | |
| Free cash flow per share | -0.06 | -0.03 | -0.03 | -0.03 | -0.02 | |
| Cash per share | 0.02 | 0.02 | 0.04 | 0.01 | 0.03 | |
| Book value per share | 0.05 | 0.03 | 0.05 | 0.03 | 0.05 | |
| Tangible book value per share | 0.04 | 0.02 | 0.05 | 0.03 | 0.05 | |
| Share holders equity per share | 0.05 | 0.03 | 0.05 | 0.03 | 0.05 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 63.22M | 174.76M | 15.27M | 22.17M | 23.17M | |
| Enterprise value | 61.7M | 172.29M | 10.48M | 20.89M | 17.95M | |
| P/E ratio | -11.87 | -28.08 | -2.12 | -3.62 | -3.38 | |
| Price to sales ratio | 383.64 | 1.16K | 187.9 | 284.55 | 182.92 | |
| POCF ratio | -9.75 | -39.53 | -3.23 | -5.25 | -6.96 | |
| PFCF ratio | -9.74 | -39.3 | -3.17 | -5.12 | -6.28 | |
| P/B Ratio | 11.4 | 48.89 | 2 | 4.21 | 2.4 | |
| PTB ratio | 11.4 | 48.89 | 2 | 4.21 | 2.4 | |
| EV to sales | 374.45 | 1.15K | 128.96 | 268.02 | 141.71 | |
| Enterprise value over EBITDA | -9.97 | -25.13 | -1.34 | -3.14 | -2.62 | |
| EV to operating cash flow | -9.51 | -38.97 | -2.22 | -4.95 | -5.39 | |
| EV to free cash flow | -9.51 | -38.75 | -2.17 | -4.83 | -4.86 | |
| Earnings yield | -0.08 | -0.04 | -0.47 | -0.28 | -0.3 | |
| Free cash flow yield | -0.1 | -0.03 | -0.32 | -0.2 | -0.16 | |
| Debt to equity | 0.04 | 0.03 | 0 | 0 | 0 | |
| Debt to assets | 0.17 | 0.29 | 0.12 | 0.09 | 0.12 | |
| Net debt to EBITDA | 0.24 | 0.36 | 0.61 | 0.19 | 0.76 | |
| Current ratio | 6.32 | 3.87 | 5.94 | 6.73 | 5.89 | |
| Interest coverage | -3.44K | -1.88K | -1.69K | -1.55K | -24.21 | |
| Income quality | 1.22 | 0.71 | 0.66 | 0.69 | 0.49 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 9.02 | 10.1 | 20.43 | 23.5 | 13.93 | |
| Research and developement to revenue | 31.96 | 34.04 | 57.79 | 34.19 | 18.73 | |
| Intangibles to total assets | 0.08 | 0.1 | 0.06 | 0.08 | 0.04 | |
| Capex to operating cash flow | 0 | 0.01 | 0.02 | 0.03 | 0.11 | |
| Capex to revenue | -0.03 | -0.17 | -1.27 | -1.37 | -2.84 | |
| Capex to depreciation | -0.04 | -0.18 | -0.77 | -1.22 | -2.11 | |
| Stock based compensation to revenue | 0.45 | 3.35 | 25.31 | 25.45 | 12.46 | |
| Graham number | 0.22 | 0.17 | 0.25 | 0.18 | 0.19 | |
| ROIC | -1.14 | -1.86 | -1.06 | -1.19 | -0.58 | |
| Return on tangible assets | -0.86 | -1.37 | -0.88 | -1.15 | -0.66 | |
| Graham Net | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | |
| Working capital | 5.02M | 3.24M | 5M | 3.05M | 6.17M | |
| Tangible asset value | 5.03M | 3.09M | 7.14M | 4.79M | 9.17M | |
| Net current asset value | 4.8M | 2.93M | 4.98M | 3.05M | 6.17M | |
| Invested capital | 0.07 | 0.07 | 0.02 | 0.01 | 0.07 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 465.02K | 541.54K | 524.78K | 329.7K | 373.89K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.96 | -1.74 | -0.95 | -1.16 | -0.71 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
IMM.L Frequently Asked Questions
What is ImmuPharma plc stock symbol ?
ImmuPharma plc is a stock and trading under the symbol IMM.L
What is ImmuPharma plc stock quote today ?
ImmuPharma plc stock price is $2.14 today.
Is ImmuPharma plc stock public?
Yes, ImmuPharma plc is a publicly traded company.